One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-126094
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 28 |
Affiliation: AbbVie (United States), Peter MacCallum Cancer Centre, Leicester Royal Infirmary, University of Valencia, Valencia Catholic University Saint Vincent Martyr, Hospital Universitario Doctor Peset, University College London Hospitals NHS Foundation Trust, University College London, Monash University, Duke Medical Center, Asklepios Klinik Altona, Japanese Red Cross Medical Center, Seoul National University Hospital, São Germano Oncologia, University Hospital Galway, University of Bologna, Mayo Clinic
T(11;14) and High BCL2 Expression Are Predictive Biomarkers of Response to Venetoclax in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Biomarker Analyses from the Phase 3 Bellini Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
